Montelukast combined with cetirizine in the treatment of refractory urticaria: A clinical observation

Journal of Clinical Dermatology

Volumn 42, Issue 5, 2013, Pages 317-318

  Zhang, Wei ^a   Xu, Xiao Yun ^a   Wang, Na ^a   Wu, Shi Yu ^a   Shi, Yu ^a  

^a Shanghai Skin Disease Hospital   (China)

Author keywords

Cetirizine; Montelukast; Refractory urticaria

Indexed keywords

CETIRIZINE; GLYCOSIDE; MONTELUKAST;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REFRACTORY URTICARIA; TREATMENT RESPONSE; TRIPTERYGIUM; UNSPECIFIED SIDE EFFECT; URTICARIA;

EID: 84880173590     PISSN: 10004963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria[J]. Allergy, 2009, 64(10): 1417-1426.
2. Morgan M, Khan DA. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1[J]. Ann Allergy Asthma Immunol, 2008, 100(5): 403-412. (Pubitemid 351668774)
3. Sanada S, Tanaka T, Kameyoshi Y, et al. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria[J]. Arch Dermatol Res, 2005, 297(3): 134-138. (Pubitemid 41425043)
4. Erbagci Z. The leukotrienereceptor antagonist montelukast in the treatment of chronic idiopathic urticaria: A single-blind, placebo-controlled, crossover clinical study[J]. J Allergy Clin Immunol, 2002, 110(3): 484-488.